Louis Edward Tamayo

CHIEF FINANCIAL OFFICER · LEXEO THERAPEUTICS, INC. · CIK 0002083206

FILING MIX · LIFETIME83%/17%

BUYS

SELLS

TOTAL VALUE

$20.8K

COMPANIES

ACTIVE SINCE

Aug 2025

HOLDINGS NOW

97,024

AVG SELL PX

$4.49

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Louis Edward Tamayo. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

LXEO · 97,024 shares · as of Jul 1, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2025

2026

FLOW · 5 buys / 1 sellsCOVERAGE · 5 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
LXEO LEXEO THERAPEUTICS, INC.	SALE Chief Financial Officer	4,641	$4.49	$20.8K	97,024	Jul 1, 2026	Jul 1, 2026 ↗	View →
LXEO LEXEO THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	12,000	—	—	101,665	Jun 29, 2026	Jul 1, 2026 ↗	View →
LXEO LEXEO THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	226,665	—	—	226,665	Feb 4, 2026	Feb 6, 2026 ↗	View →
LXEO LEXEO THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	44,665	—	—	89,665	Feb 4, 2026	Feb 6, 2026 ↗	View →
LXEO LEXEO THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	280,000	—	—	280,000	Aug 29, 2025	Sep 3, 2025 ↗	View →
LXEO LEXEO THERAPEUTICS, INC.	PURCHASEGRANT Stock grant	45,000	—	—	45,000	Aug 29, 2025	Sep 3, 2025 ↗	View →

Other insiders · LXEO

Loading peer insiders…

About this filer

CIK 0002083206

ROLE

Chief Financial Officer

PRIMARY

LXEO

COMPANIES

ACTIVE SINCE

Aug 2025

MARKETPEEL · /INSIDER/0002083206DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.